EAACI Biologicals Guidelines—Recommendations for severe asthma
Severe asthma imposes a significant burden on patients, families and healthcare systems.
Management is difficult, due to disease heterogeneity, co‐morbidities, complexity in care …
Management is difficult, due to disease heterogeneity, co‐morbidities, complexity in care …
[HTML][HTML] Effective management of severe asthma with biologic medications in adult patients: a literature review and international expert opinion
Severe asthma often remains uncontrolled despite effective treatments and evidence-based
guidelines. A group of global experts in asthma and biologic medications from 9 countries …
guidelines. A group of global experts in asthma and biologic medications from 9 countries …
Care pathways for the selection of a biologic in severe asthma
J Bousquet, G Brusselle, R Buhl… - European …, 2017 - Eur Respiratory Soc
Care pathways for the selection of a biologic in severe asthma | European Respiratory Society
Skip to main content Main menu Home Current issue ERJ Early View Past issues ERS …
Skip to main content Main menu Home Current issue ERJ Early View Past issues ERS …
Biologics for severe asthma: treatment-specific effects are important in choosing a specific agent
JG Krings, MC McGregor, LB Bacharier… - The Journal of Allergy and …, 2019 - Elsevier
Patients with uncontrolled severe persistent asthma have greater morbidity, greater use of
health care resources, and more impairment in health-related quality of life when compared …
health care resources, and more impairment in health-related quality of life when compared …
Severe asthma and biological therapy: when, which, and for whom
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary therapy, 2020 - Springer
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
Biologics for severe asthma—Which, when and why?
PA Shah, C Brightling - Respirology, 2023 - Wiley Online Library
Asthma is a common chronic inflammatory condition of the airways that affects about 350
million people globally. In 5%–10% of individuals, it is severe, with considerable morbidity …
million people globally. In 5%–10% of individuals, it is severe, with considerable morbidity …
Biologic therapies for severe asthma
GG Brusselle, GH Koppelman - New England Journal of …, 2022 - Mass Medical Soc
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a
decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may …
decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may …
Selecting the right biologic for your patients with severe asthma
LA Manka, ME Wechsler - Annals of Allergy, Asthma & Immunology, 2018 - Elsevier
Objective Severe asthma affects 5% to 10% of the adult asthma population and is
associated with increased morbidity, mortality, and consumption of health care resources …
associated with increased morbidity, mortality, and consumption of health care resources …
Biological treatments for severe asthma: a major advance in asthma care
WW Busse - Allergology International, 2019 - jstage.jst.go.jp
abstract Asthma is a heterogeneous disease with considerable variability noted in disease
severity, patterns of airway inflammation, and achievement of disease control on current …
severity, patterns of airway inflammation, and achievement of disease control on current …
Randomised controlled trials in severe asthma: selection by phenotype or stereotype
Previous publications have highlighted the disparity between research trial populations and
those in clinical practice, but it has not been established how this relates to randomised …
those in clinical practice, but it has not been established how this relates to randomised …